L5 Safety of officers in dismantling illicit synthetic opioid laboratories E/CN.7/2025/L.5 Russia: USA: We ask to ask domestic legislation domestic law OP1 , OP2 Agreed in CoW. OP7 Agreed in CoW. Poland: Can we see the paras with no agreement? PP5 Chair: Can we remove Iran´s reservation? Iran: Yes. Agreed in CoW. …
USA
Committee of the Whole – Thursday Afternoon
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 Chair: Welcome back. It has been decided no CoW meeting will take place tomorrow morning unless we make considerable strides in negotiations today and something new comes up. Thailand: We had a short informal during lunch and we …
Committee of the Whole – Thursday morning session
L6 Strengthening the global drug control framework: a path to effective implementation E/CN.7/2025/L.6 Colombia: we updated the document to reflect all recent agreements from last night, we are still working hard with delegations to find consensus across the document Chair: We start with deliberating the title, the floor is open. Sudan: it was only …
Committee of the Whole – Wednesday afternoon
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 (…) Chair: There are several paragraphs in this document that have been agreed during informals, so we will go through those first. PP1 Agreed in CoW. PP4 Agreed in CoW. PP5 Agreed in CoW PP8 Agreed in CoW PP10 …
Item 3. General Debate (Cont.)
Item 3. General Debate (Cont.) Iran. I wish to congratulate you for your election. I wish to thank the executive director for organizing this. The global issue of narcotic drugs is undergoing big issues. We are witnessing the emergence of NPS that have challenged monitoring and controlling systems. In order to have a more effective …
CND Intersessional – Session 6 – Other Substantial Matters

2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …